Citigroup’s CORINDUS VASCULAR ROBOTICS, INC CVRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-15,646
Closed -$67K 7954
2019
Q3
$67K Sell
15,646
-20,079
-56% -$72.9K ﹤0.01% 5950
2019
Q2
$106K Sell
35,725
-24,187
-40% -$60.6K ﹤0.01% 5821
2019
Q1
$104K Buy
+59,912
New +$82.8K ﹤0.01% 5710
2018
Q3
Sell
-110,973
Closed -$92K 7950
2018
Q2
$92K Buy
110,973
+97,932
+751% +$94.5K ﹤0.01% 5809
2018
Q1
$17K Buy
13,041
+2,741
+27% +$3.18K ﹤0.01% 6843
2017
Q4
$11K Buy
10,300
+10,107
+5,237% +$11.4K ﹤0.01% 7011
2017
Q3
$0 Sell
193
-60
-24% -$101 ﹤0.01% 7567
2017
Q2
$0 Buy
253
+77
+44% +$103 ﹤0.01% 7586
2017
Q1
$0 Sell
176
-55,140
-100% -$44.9K ﹤0.01% 7426
2016
Q4
$39K Buy
55,316
+50,804
+1,126% +$42.8K ﹤0.01% 6262
2016
Q3
$5K Sell
4,512
-1,029
-19% -$1.38K ﹤0.01% 6799
2016
Q2
$8K Sell
5,541
-13,154
-70% -$15.2K ﹤0.01% 6663
2016
Q1
$19K Buy
18,695
+11,908
+175% +$20.5K ﹤0.01% 6579
2015
Q4
$22K Buy
6,787
+6,783
+169,575% +$21.2K ﹤0.01% 6440
2015
Q3
$0 Sell
4
-1,409
-100% -$5.09K ﹤0.01% 7947
2015
Q2
$5K Buy
+1,413
New +$6.03K ﹤0.01% 6802

Citigroup's CVRS Position: Q4 2019 in Review

Citigroup sold out of CORINDUS VASCULAR ROBOTICS, INC (CVRS) in Q4 2019, closing a stake of 15,646 shares — an estimated $67K sold.

Citigroup first reported a position in CVRS in Q2 2015 and held it in 16 quarters. The position peaked at $106K in Q2 2019. 0 funds tracked by Wall St. Rank hold CVRS as of Q4 2019.

  • Citigroup reported no remaining CORINDUS VASCULAR ROBOTICS, INC position as of Q4 2019 after selling out during the quarter.
  • Citigroup sold 15,646 CORINDUS VASCULAR ROBOTICS, INC shares in Q4 2019, an estimated $67K.
  • Citigroup first reported a position in CORINDUS VASCULAR ROBOTICS, INC in Q2 2015 and held it in 16 quarters.
  • Citigroup's CORINDUS VASCULAR ROBOTICS, INC position peaked at $106K in Q2 2019.
  • 0 funds tracked by Wall St. Rank held CORINDUS VASCULAR ROBOTICS, INC as of Q4 2019.

Based on Citigroup's 13F filing for Q4 2019, filed 12 Feb 2020.